🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find a safe, tolerable, and efficacious dos...
Status
Terminated
Location
Local Institution - 0047
Start Date
2023-11-09
Trial ID
NCT06024174
Treatments Being Tested
This study will evaluate the safety, MTD and/or RP2D, PK, and clinical acti...
Status
Terminated
Location
Local Institution - 019-104
Start Date
2023-08-07
Trial ID
NCT05840510
Treatments Being Tested
This is a study to evaluate bioequivalence between adagrasib reference tabl...
Status
Completed
Location
Local Institution - 0003
Start Date
2025-02-04
Trial ID
NCT06801418
Treatments Being Tested
A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effe...
Status
Completed
Location
Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical Research Unit Daytona Beach)
Start Date
2023-06-29
Trial ID
NCT05924152
Treatments Being Tested
The aim of this study is to assess the pharmacokinetics, safety and tolerab...
Status
Recruiting
Location
CenExel ACT (Formerly Anaheim Clinical Trials; LLC)
Start Date
2026-08-05
Trial ID
NCT07723118
Treatments Being Tested
This is a Phase 1, open-label, multicenter, study evaluating the safety, to...
Status
Terminated
Location
Local Institution - 001-108
Start Date
2022-12-02
Trial ID
NCT05578092
This phase II trial studies how well genetic testing works in guiding treat...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-10-17
Trial ID
NCT03994796
Treatments Being Tested
This is a phase 1, open-label, single-arm study in Chinese patients with un...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2022-05-30
Trial ID
NCT05263986
Treatments Being Tested
This study will evaluate the efficacy of two dosing regimens of adagrasib (...
Status
Active Not Recruiting
Location
Local Institution - 101
Start Date
2024-02-01
Trial ID
NCT05853575
Treatments Being Tested
This first-in-human (FIH) dose-escalation and dose-validation/expansion stu...
Status
Recruiting
Location
Mayo Clinic Comprehensive Cancer Center
Start Date
2023-10-18
Trial ID
NCT06026410
Treatments Being Tested